364 related articles for article (PubMed ID: 30020021)
1. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
[TBL] [Abstract][Full Text] [Related]
2. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
3. Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
Bennett MR; Ma Q; Ying J; Devarajan P; Brunner H
Pediatr Rheumatol Online J; 2017 Oct; 15(1):74. PubMed ID: 29029629
[TBL] [Abstract][Full Text] [Related]
4. Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.
Wu CY; Yang HY; Chien HP; Tseng MH; Huang JL
Pediatr Nephrol; 2018 Jul; 33(7):1189-1198. PubMed ID: 29511890
[TBL] [Abstract][Full Text] [Related]
5. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis.
El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM
Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691
[TBL] [Abstract][Full Text] [Related]
6. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
[TBL] [Abstract][Full Text] [Related]
7. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.
Brunner HI; Bennett MR; Mina R; Suzuki M; Petri M; Kiani AN; Pendl J; Witte D; Ying J; Rovin BH; Devarajan P
Arthritis Rheum; 2012 Aug; 64(8):2687-97. PubMed ID: 22328173
[TBL] [Abstract][Full Text] [Related]
8. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
[TBL] [Abstract][Full Text] [Related]
9. Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis.
Wu Y; Yang L; Su T; Wang C; Liu G; Li XM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1954-9. PubMed ID: 20813857
[TBL] [Abstract][Full Text] [Related]
10. Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study.
Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
Medicine (Baltimore); 2016 Jan; 95(3):e2520. PubMed ID: 26817892
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis.
Zhang Q; Jiang C; Tang T; Wang H; Xia Y; Shao Q; Zhang M
Am J Med Sci; 2018 Apr; 355(4):314-321. PubMed ID: 29661344
[TBL] [Abstract][Full Text] [Related]
13. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.
Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122
[TBL] [Abstract][Full Text] [Related]
15. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
17. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis.
Urrego-Callejas T; Álvarez SS; Arias LF; Reyes BO; Vanegas-García AL; González LA; Muñoz-Vahos CH; Vásquez G; Quintana LF; Gómez-Puerta JA
Clin Rheumatol; 2021 May; 40(5):1853-1859. PubMed ID: 33079302
[TBL] [Abstract][Full Text] [Related]
18. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
[TBL] [Abstract][Full Text] [Related]
19. Prospective validation of a novel renal activity index of lupus nephritis.
Gulati G; Bennett MR; Abulaban K; Song H; Zhang X; Ma Q; Brodsky SV; Nadasdy T; Haffner C; Wiley K; Ardoin SP; Devarajan P; Ying J; Rovin BH; Brunner HI
Lupus; 2017 Aug; 26(9):927-936. PubMed ID: 28361601
[TBL] [Abstract][Full Text] [Related]
20. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Lieberthal JG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA; Monach PA;
J Rheumatol; 2013 May; 40(5):674-83. PubMed ID: 23547217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
